Invasin-functionalized PIC hydrogels enable long-term 3D culture of epithelial organoids
Proceedings of the National Academy of Sciences · 21.10.2025 · 122 (42)
DOI: 10.1073/pnas.2507500122 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 15.10.2025. Verfasst von Joost J A P M Wijnakker und 8 weiteren Autor:innen. Beteiligte Einrichtung: Oncode Institute, Hubrecht Institute, Royal Netherlands Academy of Arts and Science (KNAW), Utrecht 3584 CT, The Netherlands. Hauptthemen laut MEDLINE: Organoids, Hydrogels, Epithelial Cells, Cell Culture Techniques, Three Dimensional. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO), Oncode Institute, ZonMw (Netherlands Organisation for Health Research and Development).
Abstract (Originalsprache)
Tissue stem cell (TSC)-derived epithelial organoids are typically cultured in Matrigel [T. Sato et al. , Nature 459 , 262–265 (2009)], an extracellular matrix-like hydrogel produced from Engelbreth–Holm–Swarm sarcoma cells. This tumor is grown in the mouse abdomen [R. W. Orkin et al. , J. Exp. Med. 145 , 204–220 (1977)]. Previously, we demonstrated that the Yersinia membrane protein Invasin, coated on transwells, replaces Matrigel by activating β1-integrins, allowing long-term expansion of primary epithelial cells as 2D organoid sheets [J. J. A. P. M. Wijnakker et al. , Proc. Natl. Acad. Sci. U.S.A. 122 , e2420595121 (2025)]. Here, we functionalize a synthetic polyisocyanide (PIC) hydrogel with the integrin-activating domain of Invasin (INV). PIC hydrogels are soluble at 4 °C and form a gel at 37 °C [P. H. J. Kouwer et al. , Nature 493 , 651–655 (2013)]. When INV is covalently linked to PIC, the resulting hydrogel supports multipassage 3D growth of human intestinal and airway organoids. Self-renewal, polarization, and differentiation are maintained. The 3D swelling assay for cystic fibrosis drug testing (S. F. Boj et al. , J. Vis. Exp. (2017), 10.3791/55159] was validated using PIC-INV. With PIC-INV hydrogels, we establish a fully defined and animal-free system for 3D TSC-derived organoid culture.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Oncode Institute, Hubrecht Institute, Royal Netherlands Academy of Arts and Science (KNAW), Utrecht 3584 CT, The Netherlands.
- University Medical Centre, Utrecht 3584 CT, The Netherlands.
- Institute for Molecules and Materials, Radboud University, Nijmegen 6525 AJ, The Netherlands.
- Institute of Human Biology (IHB), Roche Pharma Research and Early Development, Roche Innovation Center, Basel 4070, Switzerland.
ORCID-Profile: Hans Clevers
Förderung
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO)
- Oncode Institute
- ZonMw (Netherlands Organisation for Health Research and Development)
Zitieren
APA
Wijnakker, J. J. A. P. M., Lim, S., Schreurs, R., Faria, J. F., Korving, J., Begthel, H., Iyer, K. K., Kouwer, P. H. J., & Clevers, H. (2025). Invasin-functionalized PIC hydrogels enable long-term 3D culture of epithelial organoids. Proceedings of the National Academy of Sciences, 122(42). https://doi.org/10.1073/pnas.2507500122
Vancouver
Wijnakker JJAPM, Lim S, Schreurs R, Faria JF, Korving J, Begthel H, et al. Invasin-functionalized PIC hydrogels enable long-term 3D culture of epithelial organoids. Proceedings of the National Academy of Sciences. 2025;122(42). doi:10.1073/pnas.2507500122
BibTeX
@article{Wijnakker2025,
author = {Wijnakker, Joost J A P M and Lim, Sangho and Schreurs, Robin and Faria, João Ferreira and Korving, Jeroen and Begthel, Harry and Iyer, Kirti K and Kouwer, Paul H J and Clevers, Hans},
title = {Invasin-functionalized PIC hydrogels enable long-term 3D culture of epithelial organoids},
journal = {Proceedings of the National Academy of Sciences},
year = {2025},
volume = {122},
number = {42},
doi = {10.1073/pnas.2507500122}
}
EUVIMED